Grant: CIHR Fellowship
Direct Payment
$150,000.00
Molecular mechanisms of the Dopamine Transporter function: The effects of drugs of abuse
FY 2011-12
Summary
Worldwide, the UN estimates that there are more than 50 million regular users of abused psychostimulants such as cocaine and amphetamine (AMPH), placing a burden on the individual and society due to its profound medical and psychological complications including dependence, overdose, and death. The addictive properties of such drugs are mediated through elevation of extracellular dopamine (DA) by inducing DA efflux via the dopamine transporter (DAT) and inhibition of DA reuptake. Neurotransmission mediated by DA in the brain is regulated through DAT function, and plays a major role in cognitive, emotional and behavioral functions. Abnormalities in the DA system have been implicated in not only drug addiction but also in other psychiatric and neurological disorders, such as schizophrenia, and Parkinson's disease. It is no wonder that DAT, the protein that carries out the DA reuptake process at the plasma membrane and also the major molecular target of AMPH and cocaine, constitutes the major focus of much research and is of major interest in developing new therapeutic strategies for drug addiction. The main objective of this project is to contribute to this field by investigating the molecular details of binding specificity and mechanistic interactions of drugs of abuse with novel 3D structural models of DAT. The binding and effects of transport of these drugs are complex and hence require a detailed understanding of both the binding modes and the dynamic consequences of the ligand-DAT interactions. To achieve our objectives, we will use technologies such as sophisticated molecular modelling methods and the use of supercomputers. The results will then guide collaborative applications of experimental techniques such as mutagenesis and chemical cross-linking to validate and incorporate our findings in the physiological and pharmacological understanding of the systems. Our study should thus prove instrumental in the design of new therapeutic approaches for drug addiction.
Department
Program
CIHR Fellowship
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
242794
Name
Sahai Michelle A
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Molecular mechanisms of the Dopamine Transporter function: The effects of drugs of abuse
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Dopamine Transporter; Drug Binding; Drug Design; Drug Of Abuse; Ligand-Receptor Interactions; Molecular Dynamics Simulations; Molecular Modelling; Mutagenesis And Chemical Cross-Linking; Neurotransmission And Neurological Disorders; Nmr And Cd
Abstract
Worldwide, the UN estimates that there are more than 50 million regular users of abused psychostimulants such as cocaine and amphetamine (AMPH), placing a burden on the individual and society due to its profound medical and psychological complications including dependence, overdose, and death. The addictive properties of such drugs are mediated through elevation of extracellular dopamine (DA) by inducing DA efflux via the dopamine transporter (DAT) and inhibition of DA reuptake. Neurotransmission mediated by DA in the brain is regulated through DAT function, and plays a major role in cognitive, emotional and behavioral functions. Abnormalities in the DA system have been implicated in not only drug addiction but also in other psychiatric and neurological disorders, such as schizophrenia, and Parkinson's disease. It is no wonder that DAT, the protein that carries out the DA reuptake process at the plasma membrane and also the major molecular target of AMPH and cocaine, constitutes the major focus of much research and is of major interest in developing new therapeutic strategies for drug addiction. The main objective of this project is to contribute to this field by investigating the molecular details of binding specificity and mechanistic interactions of drugs of abuse with novel 3D structural models of DAT. The binding and effects of transport of these drugs are complex and hence require a detailed understanding of both the binding modes and the dynamic consequences of the ligand-DAT interactions. To achieve our objectives, we will use technologies such as sophisticated molecular modelling methods and the use of supercomputers. The results will then guide collaborative applications of experimental techniques such as mutagenesis and chemical cross-linking to validate and incorporate our findings in the physiological and pharmacological understanding of the systems. Our study should thus prove instrumental in the design of new therapeutic approaches for drug addiction.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sahai, Michelle A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~